User menu

Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma

Bibliographic reference Demarez, Céline ; Hubert, Catherine ; Sempoux, Christine ; Lemaigre, Frédéric. Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma. In: PLoS One, Vol. 11, no.6, p. e0157140 (2016)
Permanent URL http://hdl.handle.net/2078.1/174707
  1. Khan Shahid A., Emadossadaty Shireen, Ladep Nimzing G., Thomas Howard C., Elliott Paul, Taylor-Robinson Simon D., Toledano Mireille B., Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?, 10.1016/j.jhep.2011.11.015
  2. Wadsworth Christopher A., Lim Adrian, Taylor-Robinson Simon D., Khan Shahid A., The risk factors and diagnosis of cholangiocarcinoma, 10.1007/s12072-012-9407-y
  3. Razumilava Nataliya, Gores Gregory J, Cholangiocarcinoma, 10.1016/s0140-6736(13)61903-0
  4. Hyder Omar, Marques Hugo, Pulitano Carlo, Marsh J. Wallis, Alexandrescu Sorin, Bauer Todd W., Gamblin T. Clark, Sotiropoulos Georgios C., Paul Andreas, Barroso Eduardo, Clary Bryan M., Aldrighetti Luca, Ferrone Cristina R., Zhu Andrew X., Popescu Irinel, Gigot Jean-Francois, Mentha Gilles, Feng Shen, Pawlik Timothy M., A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma : An Eastern and Western Experience, 10.1001/jamasurg.2013.5168
  5. Fan Linni, He Furong, Liu Hongxiang, Zhu Jin, Liu Yixiong, Yin Zhiyong, Wang Lu, Guo Ying, Wang Zhe, Yan Qingguo, Huang Gaosheng, CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma, 10.1186/1471-2407-11-320
  6. Uenishi Takahiro, Kubo Shoji, Yamamoto Takatsugu, Shuto Taichi, Ogawa Masao, Tanaka Hiromu, Tanaka Shogo, Kaneda Kenji, Hirohashi Kazuhiro, Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence, 10.1111/j.1349-7006.2003.tb01366.x
  7. Mazur Pawel K, Riener Marc-Oliver, Jochum Wolfram, Kristiansen Glen, Weber Achim, Schmid Roland M, Siveke Jens T, Expression and Clinicopathological Significance of Notch Signaling and Cell-Fate Genes in Biliary Tract Cancer, 10.1038/ajg.2011.305
  8. Plieskatt Jordan L., Rinaldi Gabriel, Feng Yanjun, Peng Jin, Yonglitthipagon Ponlapat, Easley Samantha, Laha Therawach, Pairojkul Chawalit, Bhudhisawasdi Vajarabhongsa, Sripa Banchob, Brindley Paul J., Mulvenna Jason P., Bethony Jeffrey M., Distinct miRNA signatures associate with subtypes of cholangiocarcinoma from infection with the tumourigenic liver fluke Opisthorchis viverrini, 10.1016/j.jhep.2014.05.035
  9. Antoniou Aline, Raynaud Peggy, Cordi Sabine, Zong Yiwei, Tronche François, Stanger Ben Z., Jacquemin Patrick, Pierreux Christophe E., Clotman Frederic, Lemaigre Frederic P., Intrahepatic Bile Ducts Develop According to a New Mode of Tubulogenesis Regulated by the Transcription Factor SOX9, 10.1053/j.gastro.2009.02.051
  10. Terashi Takahiro, Aishima Shinichi, Taguchi Kenichi, Asayama Yoshiki, Sugimachi Keishi, Matsuura Shuji, Shimada Mitsuo, Maehara Shinichiro, Maehara Yoshihiko, Tsuneyoshi Masazumi, Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma, 10.1111/j.1478-3231.2004.00886.x
  11. H Matsushima, Dig Liver Dis (2015)
  12. C Coffinier, Development, 129, 1829 (2002)
  13. Yu Dan-Dan, Jing Ying-Ying, Guo Shi-Wei, Ye Fei, Lu Wen, Li Quan, Dong Yu-Long, Gao Lu, Yang Yu-Ting, Yang Yang, Wu Meng-Chao, Wei Li-Xin, Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma, 10.1038/srep13319
  14. Poncy Alexis, Antoniou Aline, Cordi Sabine, Pierreux Christophe E., Jacquemin Patrick, Lemaigre Frédéric P., Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts, 10.1016/j.ydbio.2015.05.012
  15. Wang Weishan, Zhang Jing, Zhan Xuemei, Lin Tao, Yang Muyi, Hu Jing, Han Bo, Hu Sanyuan, SOX4 is associated with poor prognosis in cholangiocarcinoma, 10.1016/j.bbrc.2014.08.124
  16. Wang Xin Wei, Heegaard Niels H.H., Ørum Henrik, MicroRNAs in Liver Disease, 10.1053/j.gastro.2012.04.007
  17. Szabo Gyongyi, Bala Shashi, MicroRNAs in liver disease, 10.1038/nrgastro.2013.87
  18. Papaconstantinou Ioannis, Karakatsanis Andreas, Gazouli Maria, Polymeneas George, Voros Dionissios, The role of microRNAs in liver cancer : , 10.1097/meg.0b013e3283505063
  19. Munoz-Garrido Patricia, MicroRNAs in biliary diseases, 10.3748/wjg.v18.i43.6189
  20. Meng Fanyin, Henson Roger, Lang Molly, Wehbe Hania, Maheshwari Shail, Mendell Joshua T., Jiang Jinmai, Schmittgen Thomas D., Patel Tushar, Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines, 10.1053/j.gastro.2006.02.057
  21. Chen Lei, Yan He-Xin, Yang Wen, Hu Liang, Yu Le-Xin, Liu Qiong, Li Liang, Huang Dan-Dan, Ding Jin, Shen Feng, Zhou Wei-Ping, Wu Meng-Chao, Wang Hong-Yang, The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma, 10.1016/j.jhep.2008.09.015
  22. Kawahigashi Yutaka, Mishima Takuya, Mizuguchi Yoshiaki, Arima Yasuo, Yokomuro Shigeki, Kanda Tomohiro, Ishibashi Osamu, Yoshida Hiroshi, Tajiri Takashi, Takizawa Toshihiro, MicroRNA Profiling of Human Intrahepatic Cholangiocarcinoma Cell Lines Reveals Biliary Epithelial Cell-specific MicroRNAs, 10.1272/jnms.76.188
  23. Karakatsanis Andreas, Papaconstantinou Ioannis, Gazouli Maria, Lyberopoulou Anna, Polymeneas George, Voros Dionysios, Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance, 10.1002/mc.21864
  24. Zhang Mei-Yin, Li Shu-Hong, Huang Guo-Liang, Lin Guo-He, Shuang Ze-Yu, Lao Xiang-Ming, Xu Li, Lin Xiao-Jun, Wang Hui-Yun, Li Sheng-Ping, Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis, 10.1186/s12885-015-1067-6
  25. von Ahlfen Silke, Missel Andreas, Bendrat Klaus, Schlumpberger Martin, Determinants of RNA Quality from FFPE Samples, 10.1371/journal.pone.0001261
  26. Mosnier Jean-François, Kandel Christine, Cazals-Hatem Dominique, Bou-Hanna Chantal, Gournay Jérome, Jarry Anne, Laboisse Christian L, N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas, 10.1038/modpathol.2008.123
  27. Aishima Shin-ichi, Asayama Yoshiki, Taguchi Ken-ichi, Sugimachi Keishi, Shirabe Ken, Shimada Mitsuo, Sugimachi Keizo, Tsuneyoshi Masazumi, The Utility of Keratin 903 as a New Prognostic Marker in Mass-Forming-Type Intrahepatic Cholangiocarcinoma, 10.1097/01.mp.0000032537.82380.69
  28. Sulpice Laurent, Rayar Michel, Turlin Bruno, Boucher Eveline, Bellaud Pascale, Desille Mireille, Meunier Bernard, Clément Bruno, Boudjema Karim, Coulouarn Cédric, Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma, 10.1016/j.jss.2014.05.017
  29. C Braicu, Gastroenterology Research (2009)
  30. Sirica Alphonse E., Dumur Catherine I., Campbell Deanna J.W., Almenara Jorge A., Ogunwobi Olorunseun O., Dewitt Jennifer L., Intrahepatic Cholangiocarcinoma Progression: Prognostic Factors and Basic Mechanisms, 10.1016/j.cgh.2009.08.023
  31. Marti Patricia, Stein Claudia, Blumer Tanja, Abraham Yann, Dill Michael T., Pikiolek Monika, Orsini Vanessa, Jurisic Giorgia, Megel Philippe, Makowska Zuzanna, Agarinis Claudia, Tornillo Luigi, Bouwmeester Tewis, Ruffner Heinz, Bauer Andreas, Parker Christian N., Schmelzle Tobias, Terracciano Luigi M., Heim Markus H., Tchorz Jan S., YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors : LIVER BIOLOGY/PATHOBIOLOGY, 10.1002/hep.27992
  32. Pei Tiemin, Li Yuejin, Wang Jiabei, Wang Huanlai, Liang Yingjian, Shi Huawen, Sun Boshi, Yin Dalong, Sun Jing, Song Ruipeng, Pan Shangha, Sun Yu, Jiang Hongchi, Zheng Tongsen, Liu Lianxin, YAP is a critical oncogene in human cholangiocarcinoma, 10.18632/oncotarget.4043
  33. Plieskatt Jordan, Rinaldi Gabriel, Feng Yanjun, Peng Jin, Easley Samantha, Jia Xinying, Potriquet Jeremy, Pairojkul Chawalit, Bhudhisawasdi Vajarabhongsa, Sripa Banchob, Brindley Paul J, Bethony Jeffrey, Mulvenna Jason, A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma, 10.1186/s12885-015-1270-5
  34. Huang Ling, Holtzinger Audrey, Jagan Ishaan, BeGora Michael, Lohse Ines, Ngai Nicholas, Nostro Cristina, Wang Rennian, Muthuswamy Lakshmi B, Crawford Howard C, Arrowsmith Cheryl, Kalloger Steve E, Renouf Daniel J, Connor Ashton A, Cleary Sean, Schaeffer David F, Roehrl Michael, Tsao Ming-Sound, Gallinger Steven, Keller Gordon, Muthuswamy Senthil K, Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids, 10.1038/nm.3973
  35. Chakravarty Geetika, Rider Barbara, Mondal Debasis, Cytoplasmic compartmentalization of SOX9 abrogates the growth arrest response of breast cancer cells that can be rescued by trichostatin A treatment, 10.4161/cbt.11.1.13952
  36. Razumilava Nataliya, Gores Gregory J., Classification, Diagnosis, and Management of Cholangiocarcinoma, 10.1016/j.cgh.2012.09.009